Phase I Pilot Study of Preoperative Chemoradiation for Glioblastoma
Phase of Trial: Phase I
Latest Information Update: 17 Nov 2015
Price : $35 *
At a glance
- Drugs Temozolomide (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 09 Nov 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 03 May 2015 Planned primary completion date changed from 1 Mar 2015 to 1 Mar 2016 as per ClinicalTrials.gov.